NEW YORK, NY / ACCESSWIRE / March 2, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.
IRTC Shareholders Click Here: https://www.zlk.com/pslra-1/irhythm-technologies-inc-loss-form?prid=13231&wire=1
CLOV Shareholders Click Here: https://www.zlk.com/pslra-1/clover-health-investments-corp-loss-submission-form?prid=13231&wire=1
EH Shareholders Click Here: https://www.zlk.com/pslra-1/ehang-holdings-limited-loss-submission-form?prid=13231&wire=1
* ADDITIONAL INFORMATION BELOW *
iRhythm Technologies, Inc. (NASDAQ:IRTC)
IRTC Lawsuit on behalf of: investors who purchased August 4, 2020 - January 28, 2021
Lead Plaintiff Deadline: April 2, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/irhythm-technologies-inc-loss-form?prid=13231&wire=1
According to the filed complaint, during the class period, iRhythm Technologies, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) iRhythm's business would suffer as a result of the CMS' rulemaking; (2) reimbursement rates would in fact plummet; (3) a lack of national pricing in the CMS rule and fee schedule would cause uncertainty and weakness in the Company's business; and (4) as a result of the foregoing, Defendants' public statements were materially false and misleading at all relevant times.
Clover Health Investments, Corp. (NASDAQ:CLOV)
CLOV Lawsuit on behalf of: investors who purchased October 6, 2020 - February 3, 2021
Lead Plaintiff Deadline: April 6, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/clover-health-investments-corp-loss-submission-form?prid=13231&wire=1
According to the filed complaint, during the class period, Clover Health Investments, Corp. made materially false and/or misleading statements and/or failed to disclose that: (i) Clover was the recipient of a Civil Investigative Demand from the DOJ; (ii) much of Clover's sales are driven by a major related party deal that Clover not only failed to disclose but took active steps to conceal; (iii) Clover's
subsidiary Seek Insurance failed to disclose its relationship with Clover and misled consumers as to its purported independence; (iv) Clover's software was in fact rudimentary; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.
Ehang Holdings Limited (NASDAQ:EH)
EH Lawsuit on behalf of: investors who purchased December 12, 2019 - February 16, 2021
Lead Plaintiff Deadline: April 19, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/ehang-holdings-limited-loss-submission-form?prid=13231&wire=1
According to the filed complaint, during the class period, Ehang Holdings Limited made materially false and/or misleading statements and/or failed to disclose that: (i) the Company's purported regulatory approvals in Europe and North American for its EH216 were for use as a drone, and not for carrying passengers; (ii) its relationship with its purported primary customer is a sham; (iii) EHang
has only collected on a fraction of its reported sales since its ADS began trading on NASDAQ in December 2019; (iv) the Company's manufacturing facilities were practically empty and lacked evidence of advanced manufacturing equipment or employees; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.
You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
SOURCE: Levi & Korsinsky, LLP